Cargando…

Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin

OBJECTIVE: Rosiglitazone was found associated with approximately a 43% increase in risk of acute myocardial infarction (AMI) in a two meta-analyses of clinical trials. Our objective is to estimate the magnitude of the association in real-world patients previously treated with metformin. RESEARCH DES...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dormuth, Colin R., Maclure, Malcolm, Carney, Greg, Schneeweiss, Sebastian, Bassett, Ken, Wright, James M.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698985/ https://www.ncbi.nlm.nih.gov/pubmed/19562036 http://dx.doi.org/10.1371/journal.pone.0006080

Ejemplares similares

Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2010)

A cluster randomized trial assessing the impact of personalized prescribing feedback on antibiotic prescribing for uncomplicated acute cystitis to family physicians
por: Carney, Greg, et al.
Publicado: (2023)

Impact of rosiglitazone meta-analysis on use of glucose-lowering medications
por: Morrow, Richard L, et al.
Publicado: (2010)

Comparison of cholinesterase inhibitor safety in real-world practice
por: Carney, Greg, et al.
Publicado: (2019)

Policy‐induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia
por: Fisher, Anat, et al.
Publicado: (2019)

Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis
por: Dormuth, Colin R, et al.
Publicado: (2008)

Outcomes associated with hospital admissions for accidental opioid overdose in British Columbia: a retrospective cohort study
por: Morrow, Richard L, et al.
Publicado: (2019)

Is thiazolidinediones use a factor in delaying the need for insulin therapy in type 2 patients with diabetes? A population-based cohort study
por: Carney, Greg A, et al.
Publicado: (2012)

Prescriber preference for a particular tumour necrosis factor antagonist drug and treatment discontinuation: population-based cohort
por: Fisher, Anat, et al.
Publicado: (2014)

Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction
por: Rietbergen, Charlotte, et al.
Publicado: (2018)

Treatment pattern trends of medications for type 2 diabetes in British Columbia, Canada
por: Carney, Greg, et al.
Publicado: (2022)

Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY
Publicado: (2013)

Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT
por: Kahn, Steven E., et al.
Publicado: (2011)

Comparative Persistence of the TNF Antagonists in Rheumatoid Arthritis – A Population-Based Cohort Study
por: Fisher, Anat, et al.
Publicado: (2014)

Do proton pump inhibitors increase mortality? A systematic review and in‐depth analysis of the evidence
por: Ben‐Eltriki, Mohamed, et al.
Publicado: (2020)

Association of Previous Myocardial Infarction and Time to Presentation With Suspected Acute Myocardial Infarction
por: Troester, Valentina, et al.
Publicado: (2020)

Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia
por: Fisher, Anat, et al.
Publicado: (2022)

Rosiglitazone alleviates myocardial apoptosis in rats with acute myocardial infarction via inhibiting TLR4/NF-κB signaling pathway
por: Ma, Hongzhong, et al.
Publicado: (2020)

Rosiglitazone alleviates myocardial apoptosis in rats with acute myocardial infarction via inhibiting TLR4/NF-κB signaling pathway
por: Ma, Hongzhong, et al.
Publicado: (2021)

Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage
por: Cadarette, S. M., et al.
Publicado: (2011)

Development of Heart Failure in Medicaid Patients with Type 2 Diabetes Treated with Pioglitazone, Rosiglitazone, or Metformin
por: Breunig, Ian M., et al.
Publicado: (2014)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Metformin attenuates myocardial remodeling and neutrophil recruitment after myocardial infarction in rat
por: Soraya, Hamid, et al.
Publicado: (2015)

Comment on: TODAY Study Group. Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY. Diabetes Care 2013;36:1749–1757
por: Baldi, James C., et al.
Publicado: (2013)

The Timing of Infarction Pain in Patients with Acute Myocardial Infarction after Previous Revascularization
por: Mitrovic, Predrag M., et al.
Publicado: (2008)

Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway
por: Liu, Yuyang, et al.
Publicado: (2019)

Metformin in combination with rosiglitazone contribute to the increased serum adiponectin levels in people with type 2 diabetes mellitus
por: Nie, Jie-Ming, et al.
Publicado: (2017)

Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis
por: Fisher, Anat, et al.
Publicado: (2016)

Correction: Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis—A Meta-Analysis
por: Fisher, Anat, et al.
Publicado: (2017)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
por: DeFronzo, Ralph A., et al.
Publicado: (2010)

Incidence and Prevalence of Unrecognized Myocardial Infarction in People With Diabetes: A substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study
por: MacDonald, Michael R., et al.
Publicado: (2011)

The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction
por: Al Ali, Lawien, et al.
Publicado: (2016)

Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction
por: Loi, Halyna, et al.
Publicado: (2019)

First-Line First? Trends in Thiazide Prescribing for Hypertensive Seniors
por: Morgan, Steve, et al.
Publicado: (2005)

Management of established coronary artery disease in aircrew with previous myocardial infarction or revascularisation
por: Davenport, Eddie D, et al.
Publicado: (2019)

Circulating Total Bilirubin and Long-Term Prognosis in Patients With Previous Myocardial Infarction
por: Cao, Ye-Xuan, et al.
Publicado: (2023)

Comparative Analysis of Myocardial Viability Multimodality Imaging in Patients with Previous Myocardial Infarction and Symptomatic Heart Failure
por: Kazakauskaite, Egle, et al.
Publicado: (2022)

A systematic review and meta-analysis of the protective effects of metformin in experimental myocardial infarction
por: Hesen, Nienke A., et al.
Publicado: (2017)

Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
por: Wang, Mingyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4c7ndfo7pbm24st8e7dt56l3jp